Skip to main content

Advertisement

Table 3 HR and 95%CI for multivariate-adjusted Analysis of the ApoB/apoA1 ratio, TC/HDL-c or Framingham Risk Score to Long-term Clinical Outcomes

From: Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention

Quartiles of plasma apoB/apoAI ratios1-SD Increasing of Variablea
ApoB/apoA1 ratioQ1(n = 567)Q2(n = 568)Q3(n = 565)Q4(n = 562)
 Model 111.14 (0.66–1.88)1.12 (0.65–1.94)1.75 (1.09–2.95)1.55 (0.26–1.91)
 Model 211.15 (0.68–1.97)1.13 (0.65–1.97)1.91 (1.09–2.89)1.57 (1.28–1.93)
 Model 311.25 (0.69–2.23)1.31 (0.73–2.35)1.92 (1.10–3.13)1.59 (1.29–1.96)
Quartiles of TC/HDL-c
TC/HDL-cQ1(n = 566)Q2(n = 568)Q3(n = 563)Q4(n = 565) 
 Model 110.82 (0.52–1.32)1.09 (0.70–1.69)1.21 (0.78–1.87)1.04 (0.89–1.23)
 Model 210.78 (0.48–1.25)1.03 (0.67–1.60)1.17 (0.76–1.81)1.03 (0.87–1.23)
 Model 310.90 (0.52–1.56)1.16 (0.64–2.11)1.27 (0.56–2.89)1.02 (0.85–1.22)
Quartiles of Framingham Risk Score
Framingham Risk ScoreQ1(n = 457)Q2(n = 721)Q3(n = 603)Q4(n = 481) 
 Model 111.04 (0.63–1.70)1.00 (0.60–1.67)1.60 (0.98–2.59)1.04 (0.98–1.09)
 Model 211.37 (0.80–2.36)1.56 (0.84–2.56)2.12 (1.06–3.02)1.11 (1.04–1.18)
 Model 311.34 (0.75–2.4)1.31 (0.67–2.57)2.20 (1.08–3.56)1.08 (1.01–1.15)
  1. HR hazard ratio, CI confidence interval. Model 1, without adjustment; Model 2, adjusted for age, sex; Model 3, adjusted for Model 2, BMI, Diabetes, Hypertension, Smoking, Drinking. aHR indicates hazard ratio for per each SD increase of ApoB/apoA1 ratio, TC/HDL-c or Framingham Risk Score